Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany.

Vericore Ltd., a subsidiary of Elanco Animal Health, Inc., is a British company located in Basingstoke. The firm provides healthcare research services. It was founded in 1998. On December 18, 2000 Charles River Laboratories Edinburgh Ltd., now a subsidiary of Charles River Laboratories International, Inc. acquired Vericore Ltd. for $1.18 million.\nThe company says this about itself: The principal activity of the Company was to produce and distribute animal health pharmaceuticals. The vast majority of the Company's products were manufactured at its Dundee site.

Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. specializes in pharmaceutical research and invention. The company is headquartered in Vienna, Austria.

InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD Bioprofiling® and NPsilico®, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry’s largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs.

Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging. The Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers. The Healthcare Insights and Analytics segment provides indispensable insights to life sciences companies as well as healthcare providers and payers through a variety of high value-added data and analytics, research reports, and knowledge-based services. The company was founded on April 26, 1947 and is headquartered in Mumbai, India.

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Huzhou Tianjian Veterinary Medicine Co., Ltd., established on 2003-01-29, Business scope includes powder/Powder/Premix/tablet,oral solution,silkworm solution,disinfectant(solid),disinfectant(liquid)Production(The veterinary drug production license is valid until2018year5moon22day);veterinary medicine(Excluding veterinary biological products)Sales(The veterinary drug business license is valid until2017year6moon27day).

Stadler GmbH operates as an advertising agency. It specializes in print and digital media marketing, integrated cross-media campaigns, targeted corporate communication, as well as process management. The company is headquartered in Kirchheim unter Teck, Germany.

Fuji Latex Co., Ltd. engages in the manufacture and sale of rubber products and precision equipment. It operates through the following segments: Medical Equipment, Precision Equipment, Sales Promotion (SP), and Others. The Medical Equipment segment produces and sells condoms, balloons, probe covers and related latex products. The Precision Equipment segment manufactures and sells shock absorbers, rotary dampers and related industrial purpose buffer products. The SP segment sells balloons and promotional products. The Others segment markets food containers. The company was founded by Tadao Okamoto on March 2, 1949 and is headquartered in Tokyo, Japan.

Guangdong Bowater Biotechnology Co., Ltd., established on 2014-10-29, The business scope includes microecological preparations,bacteria,Bacteria,Feed additives,biological fertilizer,fermented feed,Healthy food,Biological product,agricultural products,Production, wholesale and retail of biological products such as antioxidants;Technology Consulting Services,Biotechnology Training,Testing of Biological Products,Identification of strains;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Samyang Genex Bio Co., Ltd. is a private company headquartered in the South Korea that manufactures medicines and antibiotics.

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Ruiwei (Shenzhen) Biotechnology Co., Ltd., established on 2019-12-17, Business scope includes general business items:drug development;Medical R&D and Trial Development;Natural science research and experimental development;Energy Technology Research,Technology Development Services;trade agent;Biotechnology Development Services;Biotechnology Extension Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Domestic Trade;Information Consulting;Operating import and export business.,The licensing program is:none

Hunan Qingtian Biotechnology Co., Ltd., established on 2014-07-25, Business scope includes plant extracts,cosmetic,hygiene products,disinfectant,Class I medical device,Class II medical device,food,Health products,Research and development of formula food for special medical purpose;Plant extracts,cosmetic,hygiene products,Class I medical device,Class II medical device,Healthy food,Infant formula,Health Supplies,Production of formula food for special medical purposes;Biotechnology Development Services;Genetically engineered drugs and vaccines,disinfectant,Manufacture of nutritious food;Sales of food additives;Primary Edible Agricultural Products,Cosmetics and hygiene products,disinfectant,Class I medical device,Class II medical device,food,Health products,Sales of formula food for special medical purposes;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Food Science and Technology Research Services;Wholesale of prepackaged food;Food Processing Technology Consulting;food production technology transfer;Engineering and Technology Research and Experimental Development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Samyang Genex Corp. engages in the manufacture of starches and glucose or maltose. Its products include glucose, starch syrup, fructose, general starch, modified starch, sorbitol, maltitol, and oligosaccharides. The company was founded on April 3, 1964 and is headquartered in Seoul, South Korea.

Kerunsheng Technology Development Co., Ltd., established on 2016-12-12, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;feed,Feed additives,Fertilizer production and sales;biological feed,Bio-organic fertilizer research and development;Import and export;Technology Import and Export;International Trade Agency Service;Domestic trade agency service(The second place of business is Emerging Industrial Park, Caofeidian District, Tangshan City, Hebei Province)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(Except those involving the implementation of special access management measures stipulated by the state)